SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

GSK's Velzatinib Receives Orphan Drug Designation in Japan for GIST

GSK said Velzatinib obtained orphan drug designation in Japan for treating gastrointestinal stromal tumors.

Related stories